BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36436909)

  • 1. The common marmoset in biomedical research: experimental disease models and veterinary management.
    Inoue T; Yurimoto T; Seki F; Sato K; Sasaki E
    Exp Anim; 2023 May; 72(2):140-150. PubMed ID: 36436909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common marmoset as a novel animal model system for biomedical and neuroscience research applications.
    Okano H; Hikishima K; Iriki A; Sasaki E
    Semin Fetal Neonatal Med; 2012 Dec; 17(6):336-40. PubMed ID: 22871417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Common Marmoset-Biomedical Research Animal Model Applications and Common Spontaneous Diseases.
    Han HJ; Powers SJ; Gabrielson KL
    Toxicol Pathol; 2022 Jul; 50(5):628-637. PubMed ID: 35535728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioacetamide-induced hepatic fibrosis in the common marmoset.
    Inoue T; Ishizaka Y; Sasaki E; Lu J; Mineshige T; Yanase M; Sasaki E; Shimoda M
    Exp Anim; 2018 Jul; 67(3):321-327. PubMed ID: 29467352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usage of common marmoset to drug discovery research].
    Sasaki E
    Nihon Yakurigaku Zasshi; 2018; 152(2):94-99. PubMed ID: 30101867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The common marmoset (Callithrix jacchus) as a model in toxicology.
    Zühlke U; Weinbauer G
    Toxicol Pathol; 2003; 31 Suppl():123-7. PubMed ID: 12597440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common marmoset as a new model animal for neuroscience research and genome editing technology.
    Kishi N; Sato K; Sasaki E; Okano H
    Dev Growth Differ; 2014 Jan; 56(1):53-62. PubMed ID: 24387631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious preclinical evaluations.
    Ando K; Inoue T; Hikishima K; Komaki Y; Kawai K; Inoue R; Nishime C; Nishinaka E; Urano K; Okano H
    Behav Pharmacol; 2020 Feb; 31(1):45-60. PubMed ID: 31625972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common marmoset (Callithrix jacchus) as a primate model for behavioral neuroscience studies.
    Prins NW; Pohlmeyer EA; Debnath S; Mylavarapu R; Geng S; Sanchez JC; Rothen D; Prasad A
    J Neurosci Methods; 2017 Jun; 284():35-46. PubMed ID: 28400103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marmoset models commonly used in biomedical research.
    Mansfield K
    Comp Med; 2003 Aug; 53(4):383-92. PubMed ID: 14524414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging.
    Dorigatti AO; Hussong SA; Hernandez SF; Sills AM; Salmon AB; Galvan V
    Geroscience; 2021 Feb; 43(1):115-124. PubMed ID: 33063253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).
    Pearce RK; Jackson M; Smith L; Jenner P; Marsden CD
    Mov Disord; 1995 Nov; 10(6):731-40. PubMed ID: 8749992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assisted reproductive technologies in the common marmoset: an integral species for developing nonhuman primate models of human diseases.
    Kropp J; Di Marzo A; Golos T
    Biol Reprod; 2017 Feb; 96(2):277-287. PubMed ID: 28203717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET analysis of dopaminergic neurodegeneration in relation to immobility in the MPTP-treated common marmoset, a model for Parkinson's disease.
    Ando K; Obayashi S; Nagai Y; Oh-Nishi A; Minamimoto T; Higuchi M; Inoue T; Itoh T; Suhara T
    PLoS One; 2012; 7(10):e46371. PubMed ID: 23056291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care.
    Yun JW; Ahn JB; Kang BC
    Lab Anim Res; 2015 Dec; 31(4):155-65. PubMed ID: 26755918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status of and Perspectives on the Application of Marmosets in Neurobiology.
    Okano H
    Annu Rev Neurosci; 2021 Jul; 44():27-48. PubMed ID: 34236888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus).
    Uehara S; Uno Y; Inoue T; Murayama N; Shimizu M; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2015 May; 43(5):735-42. PubMed ID: 25735838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.
    Ando K; Inoue T; Itoh T
    Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Related Learning and Working Memory Impairment in the Common Marmoset.
    Glavis-Bloom C; Vanderlip CR; Reynolds JH
    J Neurosci; 2022 Nov; 42(47):8870-8880. PubMed ID: 36257687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of the common marmoset to pharmacological studies].
    Nomoto M
    Nihon Yakurigaku Zasshi; 1995 Jul; 106(1):11-8. PubMed ID: 7590519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.